{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:36:20Z","timestamp":1773279380410,"version":"3.50.1"},"reference-count":47,"publisher":"Baishideng Publishing Group Inc.","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2008]]},"DOI":"10.3748\/wjg.14.2723","type":"journal-article","created":{"date-parts":[[2008,5,20]],"date-time":"2008-05-20T00:57:21Z","timestamp":1211245041000},"page":"2723","source":"Crossref","is-referenced-by-count":15,"title":["Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn\u2019s disease"],"prefix":"10.3748","volume":"14","author":[{"given":"Daniel R","family":"Beckler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sammer","family":"Elwasila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Ghobrial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh A","family":"Naser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Chiodini RJ. Crohn's disease and the mycobacterioses: a review and comparison of two disease entities. Clin Microbiol Rev 1989;2:90-117.","DOI":"10.1128\/CMR.2.1.90"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Grant IR. Zoonotic potential of Mycobacterium avium ssp. paratuberculosis: the current position. J Appl Microbiol 2005;98:1282-1293.","DOI":"10.1111\/j.1365-2672.2005.02598.x"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Chamberlin W, Graham DY, Hulten K, El-Zimaity HM, Schwartz MR, Naser S, Shafran I, El-Zaatari FA. Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. Aliment Pharmacol Ther 2001;15:337-346.","DOI":"10.1046\/j.1365-2036.2001.00933.x"},{"key":"ref4","unstructured":"Chamberlin WM, Naser SA. Integrating theories of the etiology of Crohn's disease. On the etiology of Crohn's disease: questioning the hypotheses. Med Sci Monit 2006;12:RA27-RA33."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Chiodini RJ, Van Kruiningen HJ, Thayer WR, Merkal RS, Coutu JA. Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease. Dig Dis Sci 1984;29:1073-1079.","DOI":"10.1007\/BF01317078"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Hermon-Taylor J, Bull TJ, Sheridan JM, Cheng J, Stellakis ML, Sumar N. Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis. Can J Gastroenterol 2000;14:521-539.","DOI":"10.1155\/2000\/798305"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Hermon-Taylor J. Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease. Gut 2001;49:755-756.","DOI":"10.1136\/gut.49.6.755"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Thompson DE. The role of mycobacteria in Crohn's disease. J Med Microbiol 1994;41:74-94.","DOI":"10.1099\/00222615-41-2-74"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Selby W, Pavli P, Crotty B, Florin T, Radford-Smith G, Gibson P, Mitchell B, Connell W, Read R, Merrett M. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology 2007;132:2313-2319.","DOI":"10.1053\/j.gastro.2007.03.031"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Gao A, Mutharia L, Raymond M, Odumeru J. Improved template DNA preparation procedure for detection of Mycobacterium avium subsp. paratuberculosis in milk by PCR. J Microbiol Methods 2007;69:417-420.","DOI":"10.1016\/j.mimet.2006.10.019"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 2004;364:1039-1044.","DOI":"10.1016\/S0140-6736(04)17058-X"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Romero C, Hamdi A, Valentine JF, Naser SA. Evaluation of surgical tissue from patients with Crohn's disease for the presence of Mycobacterium avium subspecies paratuberculosis DNA by in situ hybridization and nested polymerase chain reaction. Inflamm Bowel Dis 2005;11:116-125.","DOI":"10.1097\/00054725-200502000-00004"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA. Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell 2001;104:901-912.","DOI":"10.1016\/S0092-8674(01)00286-0"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Glocker E, Bogdan C, Kist M. Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany. J Antimicrob Chemother 2007;59:874-879.","DOI":"10.1093\/jac\/dkm039"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Heep M, Brandstatter B, Rieger U, Lehn N, Richter E, Rusch-Gerdes S, Niemann S. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2001;39:107-710.","DOI":"10.1128\/JCM.39.1.107-110.2001"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Jin DJ, Gross CA. Characterization of the pleiotropic phenotypes of rifampin-resistant rpoB mutants of Escherichia coli. J Bacteriol 1989;171:5229-5231.","DOI":"10.1128\/jb.171.9.5229-5231.1989"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Klein JL, Brown TJ, French GL. Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations. Antimicrob Agents Chemother 2001;45:3056-3058.","DOI":"10.1128\/AAC.45.11.3056-3058.2001"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Murphy CK, Mullin S, Osburne MS, van Duzer J, Siedlecki J, Yu X, Kerstein K, Cynamon M, Rothstein DM. In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2006;50:827-834.","DOI":"10.1128\/AAC.50.3.827-834.2006"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Obata S, Zwolska Z, Toyota E, Kudo K, Nakamura A, Sawai T, Kuratsuji T, Kirikae T. Association of rpoB mutations with rifampicin resistance in Mycobacterium avium. Int J Antimicrob Agents 2006;27:32-39.","DOI":"10.1016\/j.ijantimicag.2005.09.015"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998;79:3-29.","DOI":"10.1054\/tuld.1998.0002"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Heep M, Rieger U, Beck D, Lehn N. Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000;44:1075-1077.","DOI":"10.1128\/AAC.44.4.1075-1077.2000"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Borody TJ, Bilkey S, Wettstein AR, Leis S, Pang G, Tye S. Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars. Dig Liver Dis 2007;39:438-444.","DOI":"10.1016\/j.dld.2007.01.008"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Borody TJ, Leis S, Warren EF, Surace R. Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure? Dig Liver Dis 2002;34:29-38.","DOI":"10.1016\/S1590-8658(02)80056-1"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Chamberlin W, Ghobrial G, Chehtane M, Naser SA. Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis. Am J Gastroenterol 2007;102:689-691.","DOI":"10.1111\/j.1572-0241.2007.01040_7.x"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Gui GP, Thomas PR, Tizard ML, Lake J, Sanderson JD, Hermon-Taylor J. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. J Antimicrob Chemother 1997;39:393-400.","DOI":"10.1093\/jac\/39.3.393"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Hermon-Taylor J. Treatment with drugs active against Mycobacterium avium subspecies paratuberculosis can heal Crohn's disease: more evidence for a neglected public health tragedy. Dig Liver Dis 2002;34:9-12.","DOI":"10.1016\/S1590-8658(02)80052-4"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Shafran I, Kugler L, El-Zaatari FA, Naser SA, Sandoval J. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. Dig Liver Dis 2002;34:22-28.","DOI":"10.1016\/S1590-8658(02)80055-X"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Williams SL, Harris NB, Barletta RG. Development of a firefly luciferase-based assay for determining antimicrobial susceptibility of Mycobacterium avium subsp. paratuberculosis. J Clin Microbiol 1999;37:304-309.","DOI":"10.1128\/JCM.37.2.304-309.1999"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Pizarro TT, Cominelli F. Cytokine therapy for Crohn's disease: advances in translational research. Annu Rev Med 2007;58:433-444.","DOI":"10.1146\/annurev.med.58.121205.100607"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Hermon-Taylor J, Barnes N, Clarke C, Finlayson C. Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn's disease. BMJ 1998;316:449-453.","DOI":"10.1136\/bmj.316.7129.449"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Naser SA, Shafran I, Schwartz D, El-Zaatari F, Biggerstaff J. In situ identification of mycobacteria in Crohn's disease patient tissue using confocal scanning laser microscopy. Mol Cell Probes 2002;16:41-48.","DOI":"10.1006\/mcpr.2001.0395"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Schwartz D, Shafran I, Romero C, Piromalli C, Biggerstaff J, Naser N, Chamberlin W, Naser SA. Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients. Clin Microbiol Infect 2000;6:303-307.","DOI":"10.1046\/j.1469-0691.2000.00093.x"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Motiwala AS, Strother M, Amonsin A, Byrum B, Naser SA, Stabel JR, Shulaw WP, Bannantine JP, Kapur V, Sreevatsan S. Molecular epidemiology of Mycobacterium avium subsp. paratuberculosis: evidence for limited strain diversity, strain sharing, and identification of unique targets for diagnosis. J Clin Microbiol 2003;41:2015-2026.","DOI":"10.1128\/JCM.41.5.2015-2026.2003"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Wu CW, Glasner J, Collins M, Naser S, Talaat AM. Whole-genome plasticity among Mycobacterium avium subspecies: insights from comparative genomic hybridizations. J Bacteriol 2006;188:711-723.","DOI":"10.1128\/JB.188.2.711-723.2006"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Li L, Bannantine JP, Zhang Q, Amonsin A, May BJ, Alt D, Banerji N, Kanjilal S, Kapur V. The complete genome sequence of Mycobacterium avium subspecies paratuberculosis. Proc Natl Acad Sci USA 2005;102:12344-12349.","DOI":"10.1073\/pnas.0505662102"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Hetherington SV, Watson AS, Patrick CC. Sequence and analysis of the rpoB gene of Mycobacterium smegmatis. Antimicrob Agents Chemother 1995;39:2164-2166.","DOI":"10.1128\/AAC.39.9.2164"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Xu M, Zhou YN, Goldstein BP, Jin DJ. Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics. J Bacteriol 2005;187:2783-2792.","DOI":"10.1128\/JB.187.8.2783-2792.2005"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Ahmad S, Mokaddas E. The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Int J Antimicrob Agents 2005;26:205-212.","DOI":"10.1016\/j.ijantimicag.2005.06.009"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Aktas E, Durmaz R, Yang D, Yang Z. Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey. Microb Drug Resist 2005;11:94-99.","DOI":"10.1089\/mdr.2005.11.94"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Anthony RM, Schuitema AR, Bergval IL, Brown TJ, Oskam L, Klatser PR. Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency. Ann Clin Microbiol Antimicrob 2005;4:9.","DOI":"10.1186\/1476-0711-4-9"},{"key":"ref41","unstructured":"Bakonyte D, Baranauskaite A, Cicenaite J, Sosnovskaja A, Stakenas P. Mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Lithuania. Int J Tuberc Lung Dis 2005;9:936-938."},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Cavusoglu C, Karaca-Derici Y, Bilgic A. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Clin Microbiol Infect 2004;10:662-665.","DOI":"10.1111\/j.1469-0691.2004.00917.x"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Jou R, Chen HY, Chiang CY, Yu MC, Su IJ. Genetic diversity of multidrug-resistant Mycobacterium tuberculosis isolates and identification of 11 novel rpoB alleles in Taiwan. J Clin Microbiol 2005;43:1390-1394.","DOI":"10.1128\/JCM.43.3.1390-1394.2005"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Ma X, Wang H, Deng Y, Liu Z, Xu Y, Pan X, Musser JM, Graviss EA. rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J Clin Microbiol 2006;44:3409-3412.","DOI":"10.1128\/JCM.00515-06"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"McCammon MT, Gillette JS, Thomas DP, Ramaswamy SV, Graviss EA, Kreiswirth BN, Vijg J, Quitugua TN. Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis. Antimicrob Agents Chemother 2005;49:2200-2209.","DOI":"10.1128\/AAC.49.6.2200-2209.2005"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Yuen LK, Leslie D, Coloe PJ. Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia. J Clin Microbiol 1999;37:3844-3850.","DOI":"10.1128\/JCM.37.12.3844-3850.1999"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Greenstein RJ, Su L, Shahidi A, Brown ST. On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis. PLoS ONE 2007;2:e516.","DOI":"10.1371\/journal.pone.0000516"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i17\/2723.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T20:46:13Z","timestamp":1588711573000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i17\/2723.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":47,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.14.2723","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}